Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Blood Flow Measurement Boosts Stent Outcomes

Technology reduces deaths, complications, but may be too costly for some centers, experts say

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Shutting Down Tremor.
Disaster Heart Attacks
Teaching Old Docs New Tricks
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Drugs Provide Same Benefit as Angioplasty for Diabetics, at Lower Cost
Study: Migraine Raises Risk of Stroke
Low Vitamin D Tied to Estrogen Decline
All Ages at Risk for H1N1 Complications
More...

WEDNESDAY, Jan. 14 (HealthDay News) -- A sophisticated measure of blood flow to determine where artery-opening stents should be implanted is more effective than the X-ray examinations now commonly used, an international study finds.

The technique, measuring what's known as "fractional flow reserve" (FFR), is designed for people who have multiple blockages that require artery-opening procedures such as angioplasty, followed by implantation of the flexible tubes called stents, explained study co-author Dr. Nico H. J. Pijls, professor of cardiology at the Catharina Hospital in Eindhoven, the Netherlands.

Text Continues Below



Such multiple blockages are seen in about 60 percent of cases, said Pijls, a leader in development of the flow-measuring technology.

The team published their findings in the Jan. 16 issue of the New England Journal of Medicine. The research was funded in part by Radi Medical Systems, which makes the FFR device tested in the trial.

The study, carried out in 20 European and U.S. medical centers, compared patient outcomes for stent implants using either FFR measurements or angiography (X-ray images) in 1,005 people who underwent artery-opening procedures.

Over a year of follow-up, 13.2 percent of those whose stents were implanted by the FFR method died, had major coronary events such as heart attacks or needed new procedures, compared to 18.3 percent of those in the X-ray group.

The cost of their treatment was lower, averaging $5,332 for the FFR cases against $6,007 for the angiography-guided group. The lower cost was due in part to the use of fewer stents in the FFR cases, an average of 1.9 versus 2.7 stents in the angiography group.

That's a real advantage, Pijls said, because, "you can do it in a more refined way. There are fewer complications, because instead of shooting for all stenoses [blockages], you can use stents only on those that are dangerous for the patient."

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 1/14/2009

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: Nico H. J. Pijls, M.D., Ph.D., professor, cardiology, Catharina Hospital, Eindhoven, the Netherlands; Stephen G. Ellis, M.D., director, cardiac catheterization laboratory, Cleveland Clinic; Jan. 16, 2009, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service    
Advertising Policy

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.